DataMeds AI has teamed up with Tollo Health and the NFL Alumni Association’s health subsidiary to debut the Health Lives Here campaign, focusing on expanding healthcare access and resources, especially in underserved and rural areas. This initiative is set to enhance public awareness regarding healthy lifestyles while also offering affordable pharmacy services and healthcare tools. Central to this campaign is DataMeds AI’s extensive network of over 6,500 independent pharmacies, which will play a significant role in reaching a wide demographic.
At the heart of the Health Lives Here campaign is a soon-to-be-released mobile application designed to serve as a comprehensive telehealth and health-management platform. This app will allow users to consolidate their electronic health records and integrate data from wearable health devices into a single, user-friendly health dashboard. Furthermore, it will facilitate access to pharmacy services and feature a selection of healthcare products, aiming to empower consumers by providing them with vital health-management tools.
DataMeds AI and Tollo Health revealed this initiative to former professional football players during the 2026 Football Hall of Fame Game weekend in Canton, Ohio. A broader public launch is scheduled to commence in North Carolina in September 2026. As the campaign unfolds, more information will become available regarding the specifics of the mobile application, the pharmacies participating, and the overall rollout strategy.
The collaboration merges Tollo Health’s expertise in medical food and nutraceuticals with DataMeds AI’s advanced healthcare technology and pharmacy infrastructure. This synergy is further strengthened by the NFL Alumni Association’s health network, which will aid in reaching both communities and former football players, ensuring the campaign’s message and resources are effectively communicated.
For further inquiries, DataMeds AI has provided contact details for their media and investor relations. James Lambert, Vice President at Rubenstein Public Relations, is available via phone at 212-805-3024 or email at [email protected]. Investors can reach out via [email protected], and more information is accessible on their website at https://datamedsai.com/.
Legal Disclaimer: The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.